Definitive Healthcare Receives $1.02/Share Acquisition Proposal

What Happened

• On September 2, 2026, Definitive Healthcare Corp. announced that its Special Committee received a non‑binding proposal from Advent International, L.P. (on behalf of certain managed funds) to acquire all outstanding Class A common stock and AIDH TopCo, LLC limited liability interests (Definitive OpCo Units) not already owned by Advent and founder/Executive Chairman Jason Krantz.
• The proposed purchase price is $1.02 per share of Class A common stock and an equivalent amount per Definitive OpCo Unit, payable all in cash. The announcement was made via a press release filed as Exhibit 99.1 to the 8‑K.

Key Details

• Date filed: September 2, 2026 (8‑K Item 8.01; press release attached as Exhibit 99.1).
• Buyer: Advent International, L.P., on behalf of certain of its managed funds.
• Offer: Non‑binding, all‑cash proposal of $1.02 per Class A share and equivalent per OpCo unit.
• Targets: All outstanding Class A common stock and AIDH TopCo, LLC interests not already owned by Advent and Jason Krantz.

Why It Matters

• This is a potential takeover proposal at a specific cash price that could affect the market price and trading of Definitive Healthcare shares.
• The proposal is non‑binding and the filing does not announce any agreement, timetable, or definitive transaction—so there is no certainty the deal will occur.
• Investors should watch for further disclosures about the Special Committee’s review, any definitive agreement, financing details, or competing bids, which would materially affect the company's prospects and stock valuation.